MR spectroscopy moves from the brain to bones
Characterizing musculoskeletal tumors with MR spectroscopy could eliminate the need for standard imaging and histological staging. Researchers at Johns Hopkins University have found preliminary success using MRS at 3T to diagnose bone tumors.
Characterizing musculoskeletal tumors with MR spectroscopy could eliminate the need for standard imaging and histological staging. Researchers at Johns Hopkins University have found preliminary success using MRS at 3T to diagnose bone tumors.
Dr. Laura M. Fayad, an assistant professor of radiology, and colleagues examined six bone tumors. They correctly detected a choline peak in two malignant cases and no choline peak in four benign cases, Fayad told Diagnostic Imaging.
The group had previously been successful in using MRS at 1.5T to investigate resected tumors. Fayad reported that study at the 2004 RSNA meeting.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
